Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Natera, Inc. (NTRA : NSDQ)
 
 • Company Description   
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

Number of Employees: 6,140

 
 • Price / Volume Information   
Yesterday's Closing Price: $261.99 Daily Weekly Monthly
20 Day Moving Average: 1,284,856 shares
Shares Outstanding: 143.21 (millions)
Market Capitalization: $37,520.89 (millions)
Beta: 1.51
52 Week High: $288.04
52 Week Low: $131.81
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.48% -0.26%
12 Week 27.08% 23.60%
Year To Date 14.36% 6.76%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
13011 McCallen Pass Building A Suite 100
-
Austin,TX 78753
USA		 ph: 650-980-9190
fax: -		 investor@natera.com http://www.natera.com
 
 • General Corporate Information   
Officers
Steve Chapman - Chief Executive Officer and President
Matthew Rabinowitz - Executive Chairman
Michael Brophy - Chief Financial Officer
Roy Baynes - Director
Monica Bertagnolli - Director

Peer Information
Natera, Inc. (CHCR)
Natera, Inc. (ESRX)
Natera, Inc. (MYDP)
Natera, Inc. (COR)
Natera, Inc. (GBCS)
Natera, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 632307104
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/06/26
Share - Related Items
Shares Outstanding: 143.21
Most Recent Split Date: (:1)
Beta: 1.51
Market Capitalization: $37,520.89 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.31 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.49 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 21.01
Price/Cash Flow: -
Price / Sales: 15.00
EPS Growth
vs. Year Ago Period: -12.00%
vs. Previous Quarter: -260.00%
Sales Growth
vs. Year Ago Period: 38.82%
vs. Previous Quarter: 4.68%
ROE
06/30/26 - -
03/31/26 - -14.74
12/31/25 - -15.28
ROA
06/30/26 - -
03/31/26 - -10.27
12/31/25 - -10.80
Current Ratio
06/30/26 - -
03/31/26 - 2.96
12/31/25 - 3.39
Quick Ratio
06/30/26 - -
03/31/26 - 2.83
12/31/25 - 3.24
Operating Margin
06/30/26 - -
03/31/26 - -8.82
12/31/25 - -9.03
Net Margin
06/30/26 - -
03/31/26 - -9.05
12/31/25 - -9.03
Pre-Tax Margin
06/30/26 - -
03/31/26 - -11.44
12/31/25 - -11.62
Book Value
06/30/26 - -
03/31/26 - 12.47
12/31/25 - 12.38
Inventory Turnover
06/30/26 - -
03/31/26 - 13.54
12/31/25 - 13.68
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
Debt-to-Capital
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
 

Powered by Zacks Investment Research ©